The use of Stem Cells for COVID-19 Therapy

There are now numerous uses and investigations for experimental stem cell therapy in severely ill COVID-19 patients, particularly MSC therapy. MSCs are produced from the mesoderm and ectoderm during the early stages of embryonic development, and they have gotten a lot of press because of their multidirectional differentiation capability, immunomodulatory capabilities, and lack of ethical issues. stem cell treatment offers extensive clinical application possibilities and far-reaching relevance thanks to the ongoing exploration of stem cell clinical research and data mining.

    Related Conference of The use of Stem Cells for COVID-19 Therapy

    September 24-25, 2026

    7th Annual summit on Cell Signaling and Cancer Therapy

    Paris, France